We look forward to engaging with global leaders from across sectors at this year’s Milken Institute Global Conference, happening May 5 through 8, in Los Angeles.
The theme of this year’s conference, “Shaping a Shared Future,” reflects ongoing global disruptions as well as promising innovations—all of which impact our shared future. BCG experts, along with cross-industry leaders—including CEOs, investors, policymakers, academics, and thought leaders—will convene at Milken to discuss the various challenges and opportunities. At BCG, our experts are continuously exploring the elements that will ready companies for the future and that will make the world a better place. This means developing the ability to anticipate trends in digital and AI, health care, geopolitics and global trade, climate and climate financing, among other areas—and then to build strengths to influence these trends for competitive and societal advantage.
Featuring: BCG's Greg Emerson
The economy’s intersection with tech and innovation has a tremendous impact on the way we live, connect, and work. Innovation, data sets, and computing capabilities continue to grow at exponential rates.
Our BCG delegation will bring to the conference deep expertise, knowledge, and experience across sectors:
We’re a trusted partner to the top ten private equity firms and tech investors, and we’ve assisted nearly 70% of the top 60 tech capital investors globally.
We have partnered with companies around the world to uncover and address DEI gaps among their workforce, products and services, and suppliers.
We are a supporting partner of the ESG Data Convergence Initiative (EDCI), a first-of-its-kind, industry-led effort to drive convergence on meaningful ESG metrics for the private equity industry.
We work with clients across the health care value chain, from pharmaceutical R&D, to corporate M&A, to digital and AI, and beyond.
We’re collaborating with OpenAI to help our clients realize the power of OpenAI technologies and solve the most complex challenges using generative AI—responsibly. We have successfully supported clients on their energy transition journeys by reducing their emissions and expanding their low-carbon technology initiatives, thereby unlocking new efficiencies, opportunities, and value.
Meet our leaders who will be onsite at the 2024 conference. We are looking forward to engaging with other experts, critical thinkers, and stakeholders on geopolitical, climate, and technology challenges to drive progress and prosperity, together.
Managing Director & Partner
San Francisco - Bay Area
As the market recovers in 2024, multiple trends affecting providers, payers, pharma, medtech, and life science tools will shape how private equity investors plan to play.
BCG’s survey of 1,400+ C-suite executives reveals that GenAI is quickly changing the way companies do business—and big gaps are emerging between the winners and the observers.
Recent macroeconomic headwinds have slowed investment and dealmaking in private infrastructure, but new investment is primed to grow, with strong and stable results likely.
Hundreds of PE firms have reported data detailing the progress that their portfolio companies are making on social and climate-related issues. The results are encouraging.
Sheila Patel talks about key areas for investment over the next four to five years.
Dr. Alexandra Bause explains how today’s reactive approach provides sick care, not health care—and how biopharma strives to change that.
Given the rapid pace of workplace change, BCG’s Rich Lesser says, it’s vital to attract, retain, and develop high-caliber people.
